Previous 10 | Next 10 |
home / stock / tdsgf / tdsgf news
2023-06-30 09:59:22 ET Telo Genomics ( OTCQB:TDSGF ) has entered into an agreement with Leede Jones Gable to compensate Leede for strategic advice provided in connection with the Company's recently closed $0.25 non-brokered private placement. Under the agreement, the Co. will ...
Toronto, Ontario--(Newsfile Corp. - June 30, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the " Company " or " TELO ") announces that it has entered into an agreement with Leede Jones Gable Inc. (" Leede ") to compensate Leede for strategic advice provided in connection with the Com...
Toronto, Ontario--(Newsfile Corp. - June 14, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the " Company " or " Telo ") announces that it has closed its previously announced non-brokered private placement (" Offering ") of units (the " Units "). The Company issued a total of 11,335...
Toronto, Ontario--(Newsfile Corp. - June 12, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) ( the "Company" or "Telo") presented the results of its latest study on Friday June 09, 2023 at the European Hematology Association (EHA) 2023 annual meeting. This study, executed in conjunct...
Toronto, Ontario--(Newsfile Corp. - June 6, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the " Company " or " TELO ") is pleased to announce that it has increased the size of its previously announced non-brokered private placement (" Offering ") from up to $2 million in proceeds to ...
Toronto, Ontario--(Newsfile Corp. - June 5, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) ( the "Company" or "Telo") is excited to announce that the results of its smoldering multiple myeloma (SMM) studies that were conducted in collaboration with the Mayo Clinic were presented ear...
2023-05-19 09:17:52 ET Telo Genomics ( TSXV: TELO:CA ) ( OTCQB:TDSGF ) on Friday announced a non-brokered private placement of units to raise $2 million. The company plans to offer units at 25 cents apiece, which would translate to an offering of about 8 million units to r...
Toronto, Ontario--(Newsfile Corp. - May 19, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the " Company " or " Telo ") is pleased to announce a non-brokered private placement of units (" Units ") at a price of $0.25 per Unit for gross proceeds of $2,000,000 (the " Offering "). Each...
Telo Genomics ( OTCQB:TDSGF ) has announced the appointment of Kris Weinberg as Chief Executive Officer, effective today. Telo Genomics' current CEO, Sherif Louis PhD, will assume the position of President & Chief Technology Officer. For further details see: Telo Ge...
Toronto, Ontario--(Newsfile Corp. - December 12, 2022) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) ( the "Company" or "TELO") is pleased to announce the appointment of Kris Weinberg as Chief Executive Officer ("CEO"), effective today. Telo Genomics' current CEO, Sherif Louis PhD, will ...
News, Short Squeeze, Breakout and More Instantly...
Teledata Singapore Ltd Company Name:
TDSGF Stock Symbol:
OTCMKTS Market:
Teledata Singapore Ltd Website:
Toronto, Ontario--(Newsfile Corp. - June 18, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) ( the "Company" or "Telo") a biotech company developing the industry's leading telomere technology platform with diagnostic and prognostic applications measuring genomic instability in oncolo...
Toronto, Ontario--(Newsfile Corp. - June 12, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3D0A) ("Telo" or the "Company"), is pleased to announce that results of the development, validation and implementation of its machine learning and Artificial Intelligence (AI) modules, u...
Toronto, Ontario--(Newsfile Corp. - May 30, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA), ( the "Company" or "Telo"), a biotech company developing the industry's leading telomere technology platform with diagnostic and prognostic applications in oncology, is thrilled t...